The firm said Jan. 18 that the system consists of a triangulation platform and an instrument for tissue piercing and approximation that can be affixed to an array of different endoscopes. The system enables suturing similar to what a laparoscopic approach allows, while using only natural orifices for an incisionless procedure.
Endo Tools Therapeutics said it’s planning a limited U.S. market release in the first half of 2022, with a wider release later in the year.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
